Develops next-generation gene therapies by designing novel AAV capsids to improve targeting, safety, and efficacy for serious diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Affinia Therapeutics develops next-generation gene therapies using its proprietary platform to rationally design novel adeno-associated virus (AAV) capsids for improved targeting, safety, and efficacy. The company focuses on creating transformative treatments for devastating rare and prevalent diseases, starting with conditions affecting the heart and nervous system.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Affinia Therapeutics Management Team
Investors
Alexandria Venture Investments
Atlas Venture Advisors Inc
F-Prime
Lonza
New Enterprise Associates Inc (NEA)
Partners Innovation Fund LLC
Affinia Therapeutics Valuations & Financials
View real-time NPM data on Affinia Therapeutics stock including daily Affinia Therapeutics stock price estimates, valuation history, and historical share price information. Access Affinia Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Affinia Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Affinia Therapeutics? Get in touch to learn more.
Similar Companies
like Affinia Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Zazzle
Commerce & Marketplaces
Online marketplace and manufacturing platform enabling users to design, create and sell custom products including apparel, posters, and cards.
Candu
Operates a low-code visual editor to design and embed personalized user interfaces directly within web applications.
Ordoro
Commerce & Marketplaces
Automating post‑checkout workflows that synchronize inventory, generate shipping labels, and manage supplier routing for seamless ecommerce fulfillment.
AIxMed
Provides a computational cytology platform which utilizes deep learning computer vision to automate the detection of abnormal cells in digital pathology samples.
Vima Therapeutics
Healthcare & Life Sciences
Develops oral neuromodulators that target core disease mechanisms to restore movement control and improve patient outcomes.
Survios
Specializes in creating immersive, action-packed video games with a focus on virtual reality and cinematic player experiences.
Better Meat
Consumer
Enhancing that enriches meat with a clean‑label mycoprotein via fermentation for better texture, nutrition, and sustainability.
RepRisk
Technology company providing ESG risk data and analytics through machine learning and human analysis to assess environmental and social risks.
FAQ
We have answers
Affinia Therapeutics stock does not trade on public stock exchanges. Affinia Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Affinia Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Affinia Therapeutics Stock does not trade on public stock exchanges. In order to sell Affinia Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Affinia Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Affinia Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Affinia Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Affinia Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Affinia Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Affinia Therapeutics is a private company and has not had an IPO. There is currently no Affinia Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Affinia Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
